Literature DB >> 15811994

Proteomic profiling of recombinant Escherichia coli in high-cell-density fermentations for improved production of an antibody fragment biopharmaceutical.

Ilana S Aldor1, Denise C Krawitz, William Forrest, Christina Chen, Julie C Nishihara, John C Joly, Kathleen M Champion.   

Abstract

By using two-dimensional polyacrylamide gel electrophoresis, a proteomic analysis over time was conducted with high-cell-density, industrial, phosphate-limited Escherichia coli fermentations at the 10-liter scale. During production, a recombinant, humanized antibody fragment was secreted and assembled in a soluble form in the periplasm. E. coli protein changes associated with culture conditions were distinguished from protein changes associated with heterologous protein expression. Protein spots were monitored quantitatively and qualitatively. Differentially expressed proteins were quantitatively assessed by using a t-test method with a 1% false discovery rate as a significance criterion. As determined by this criterion, 81 protein spots changed significantly between 14 and 72 h (final time) of the control fermentations (vector only). Qualitative (on-off) comparisons indicated that 20 more protein spots were present only at 14 or 72 h in the control fermentations. These changes reflected physiological responses to the culture conditions. In control and production fermentations at 72 h, 25 protein spots were significantly differentially expressed. In addition, 19 protein spots were present only in control or production fermentations at this time. The quantitative and qualitative changes were attributable to overexpression of recombinant protein. The physiological changes observed during the fermentations included the up-regulation of phosphate starvation proteins and the down-regulation of ribosomal proteins and nucleotide biosynthesis proteins. Synthesis of the stress protein phage shock protein A (PspA) was strongly correlated with synthesis of a recombinant product. This suggested that manipulation of PspA levels might improve the soluble recombinant protein yield in the periplasm for this bioprocess. Indeed, controlled coexpression of PspA during production led to a moderate, but statistically significant, improvement in the yield.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15811994      PMCID: PMC1082529          DOI: 10.1128/AEM.71.4.1717-1728.2005

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  38 in total

1.  Kinetics of heat-shock response and inclusion body formation during temperature-induced production of basic fibroblast growth factor in high-cell-density cultures of recombinant Escherichia coli.

Authors:  F Hoffmann; U Rinas
Journal:  Biotechnol Prog       Date:  2000 Nov-Dec

2.  Similarity of the Escherichia coli proteome upon completion of different biopharmaceutical fermentation processes.

Authors:  K M Champion; J C Nishihara; J C Joly; D Arnott
Journal:  Proteomics       Date:  2001-09       Impact factor: 3.984

3.  Effect of overproduction of heat shock chaperones GroESL and DnaK on human procollagenase production in Escherichia coli.

Authors:  S C Lee; P O Olins
Journal:  J Biol Chem       Date:  1992-02-15       Impact factor: 5.157

4.  Role of ribosome degradation in the death of starved Escherichia coli cells.

Authors:  B D Davis; S M Luger; P C Tai
Journal:  J Bacteriol       Date:  1986-05       Impact factor: 3.490

Review 5.  Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12.

Authors:  A J Link; K Robison; G M Church
Journal:  Electrophoresis       Date:  1997-08       Impact factor: 3.535

6.  Comparison of the Escherichia coli proteomes for recombinant human growth hormone producing and nonproducing fermentations.

Authors:  Kathleen M Champion; Julie C Nishihara; Ilana S Aldor; G Tony Moreno; Dana Andersen; Kathy L Stults; Martin Vanderlaan
Journal:  Proteomics       Date:  2003-07       Impact factor: 3.984

7.  High-level accumulation of a recombinant antibody fragment in the periplasm of Escherichia coli requires a triple-mutant (degP prc spr) host strain.

Authors:  Christina Chen; Brad Snedecor; Julie C Nishihara; John C Joly; Nancy McFarland; Dana C Andersen; John E Battersby; Kathleen M Champion
Journal:  Biotechnol Bioeng       Date:  2004-03-05       Impact factor: 4.530

8.  Plasmid-encoded protein: the principal factor in the "metabolic burden" associated with recombinant bacteria.

Authors:  W E Bentley; N Mirjalili; D C Andersen; R H Davis; D S Kompala
Journal:  Biotechnol Bioeng       Date:  1990-03-25       Impact factor: 4.530

Review 9.  Escherichia coli--a model system that benefits from and contributes to the evolution of proteomics.

Authors:  Pat S Lee; Kelvin H Lee
Journal:  Biotechnol Bioeng       Date:  2003-12-30       Impact factor: 4.530

10.  Gratuitous overexpression of genes in Escherichia coli leads to growth inhibition and ribosome destruction.

Authors:  H Dong; L Nilsson; C G Kurland
Journal:  J Bacteriol       Date:  1995-03       Impact factor: 3.490

View more
  11 in total

1.  Recombinant E. coli expressing Vitreoscilla haemoglobin prefers aerobic metabolism under microaerobic conditions: a proteome-level study.

Authors:  Bini Ramachandran; Kanak Lata Dikshit; Kuppamuthu Dharmalingam
Journal:  J Biosci       Date:  2012-09       Impact factor: 1.826

2.  Host cell protein dynamics in recombinant CHO cells: impacts from harvest to purification and beyond.

Authors:  Catherine Em Hogwood; Daniel G Bracewell; C Mark Smales
Journal:  Bioengineered       Date:  2013-01-17       Impact factor: 3.269

Review 3.  The Escherichia coli proteome: past, present, and future prospects.

Authors:  Mee-Jung Han; Sang Yup Lee
Journal:  Microbiol Mol Biol Rev       Date:  2006-06       Impact factor: 11.056

Review 4.  Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells.

Authors:  Aleš Berlec; Borut Strukelj
Journal:  J Ind Microbiol Biotechnol       Date:  2013-02-06       Impact factor: 3.346

5.  Co-expression of Skp and FkpA chaperones improves cell viability and alters the global expression of stress response genes during scFvD1.3 production.

Authors:  Dave Siak-Wei Ow; Denis Yong-Xiang Lim; Peter Morin Nissom; Andrea Camattari; Victor Vai-Tak Wong
Journal:  Microb Cell Fact       Date:  2010-04-13       Impact factor: 5.328

6.  Protein solubility and differential proteomic profiling of recombinant Escherichia coli overexpressing double-tagged fusion proteins.

Authors:  Chung-Hsien Cheng; Wen-Chien Lee
Journal:  Microb Cell Fact       Date:  2010-08-28       Impact factor: 5.328

7.  Bioprocess scale-up/down as integrative enabling technology: from fluid mechanics to systems biology and beyond.

Authors:  Frank Delvigne; Ralf Takors; Rob Mudde; Walter van Gulik; Henk Noorman
Journal:  Microb Biotechnol       Date:  2017-08-14       Impact factor: 5.813

8.  Automation of Dead End Filtration: An Enabler for Continuous Processing of Biotherapeutics.

Authors:  Garima Thakur; Vishwanath Hebbi; Subhash Parida; Anurag S Rathore
Journal:  Front Bioeng Biotechnol       Date:  2020-07-03

9.  Significant rewiring of the transcriptome and proteome of an Escherichia coli strain harboring a tailored exogenous global regulator IrrE.

Authors:  Tingjian Chen; Jianqing Wang; Lingli Zeng; Rizong Li; Jicong Li; Yilu Chen; Zhanglin Lin
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

10.  Bax expression is optimal at low oxygen tension and constant agitation.

Authors:  Yi He; Yong Chen; Daniel L Morris; Duck-Yeon Lee; Nico Tjandra
Journal:  Protein Expr Purif       Date:  2019-09-19       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.